Atlas Trials

2nd Line Erlotinib Treatment With (Out) Chemotherapy of Advanced Non Small Cell Lung Cancer (NSCLC)

Clinical trial NCT00835471 · COMPLETED

Trial details

NCT number
NCT00835471
Sponsor
Dutch Society of Physicians for Pulmonology and Tuberculosis
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Non-Small-Cell Lung
Start date
2009-03-01
Primary completion
2014-06-01
Enrollment
195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.